ask="1.7700"
ask_size="400"
average_daily_volume="50208"
bid="1.6700"
bid_size="500"
book_value="0.8110"
change="+0.0399"
change_from_200_day_moving_average="-0.1073"
change_from_50_day_moving_average="0.1429"
change_from_52_week_high="-2.2001"
change_From_52_week_low="0.4799"
change_in_percent="+2.4036%"
close="1.6999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-6.98M"
eps_estimate_current_year="-0.1600"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.4800"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.7700"
high_52_weeks="3.9000"
last_trade_date="1/27/2017"
last_trade_price="1.6999"
last_trade_size="200"
last_trade_time="3:55pm"
low="1.6700"
low_52_weeks="1.2200"
market_capitalization="18.68M"
moving_average_200_day="1.8072"
moving_average_50_day="1.5570"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.0000"
open="1.6700"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-5.9358%"
percent_change_from_50_day_moving_average="+9.1800%"
percent_change_from_52_week_high="-56.4128%"
percent_change_from_52_week_low="+39.3361%"
previous_close="1.6600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.0469"
price_per_sales="4.8019"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="CBLI"
volume="19243"
weeks_range_52="1.2200 - 3.9000"
